Crosslinked poly(allylamine) polymer pharmaceutical compositions
US10934380B1 · kind B1 · utility
4Cited by
15References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 21, 2018 |
| Grant date | Mar 2, 2021 |
| Priority date | — |
| Expiry date | Sep 21, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08G73/024
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of a target species from the gastrointestinal tract would provide physiological benefits.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.